The AGTR2 gene gives your body instructions for a receptor that responds to angiotensin II, a hormone that helps control blood vessel tone, salt balance, and parts of early development. What this gene does can influence how your body manages blood pressure and how some tissues form before birth. If the gene does not work as expected, it may contribute to changes in blood pressure control or, in some families, developmental differences. Because it is on the X chromosome, effects can vary between males and females.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or direct processes throughout the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
AGTR2Gene function
What if the gene works
The AGTR2 gene helps cells respond to angiotensin II, a hormone that affects blood vessels and fluid balance. It supports blood vessel relaxation and plays a part in growth and development, especially before birth.
Risk
What if the gene does not work
Milder and more severe variants in the AGTR2 gene can partly reduce or more strongly disrupt cell signaling through the angiotensin II type 2 receptor. This can alter how some cells regulate growth, development, and responses to hormonal signals.
Treatment
What does that mean for your treatment
No AGTR2-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the AGTR2 gene. The AGTR2 gene is being studied as a signaling pathway and possible drug target in cardiovascular, kidney, and nerve-related research, but this has not led to guideline-based treatment choices.
Conditions associated with AGTR2
Gene function
What if the gene works
This gene helps your body respond to angiotensin II, a natural signal that influences blood vessels and developing organs. It is especially active before birth, when tissues are forming and blood flow patterns are being tuned. Understanding AGTR2 gene function helps explain how the body fine tunes circulation and organ growth.
The AGTR2 gene makes a receptor on the cell surface that recognizes angiotensin II. Once that signal binds, the receptor passes instructions inward so the cell can adjust its activity.
In blood vessel walls, this receptor helps fine tune how strongly vessels tighten or relax. That local control supports steadier circulation and helps match blood flow to tissue needs.
Activity from this gene is highest before birth, when it helps guide how organs and tissues take shape. It plays a part in the developing kidneys, blood vessels, and nervous system.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body reacts to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AGTR2 gene can alter the receptor’s shape, reduce its stability, or keep it from reaching the cell surface, so cells respond less well to angiotensin II signals. Research on how variants in the AGTR2 gene affect receptor signaling shows a spectrum, from milder changes that partly reduce signaling to more severe variants that greatly weaken binding to the signal molecule or shut signaling down almost completely. This range can change how strongly cell messages are passed on.
How variants are linked to conditions
The AGTR2 gene does not yet have a broadly confirmed link to a specific health condition, though research continues and reported associations may be refined over time. Because evidence on how AGTR2 gene variants are linked to conditions is still developing, anyone with a confirmed variant in the AGTR2 gene should rely on guidance from their clinician or genetic counselor for personal interpretation.
A variant is not necessarily a diagnosis
Variants in DNA are a normal feature of human biology and are widely seen across the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, one well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the AGTR2 gene. AGTR2 may play a small part in blood pressure and heart-related traits, but overall risk is also shaped by many other genes, age, sex, and everyday factors such as smoking, diet, and exercise.
Inheritance of AGTR2 variants
There is not yet a broadly confirmed, disease-specific Mendelian pattern for AGTR2 gene inheritance, and research is still clarifying whether certain AGTR2 variants consistently cause a defined inherited condition. The AGTR2 gene is located on the X chromosome, so any AGTR2 variant follows X linked transmission rather than autosomal inheritance. In families, that means inheritance can differ between sons and daughters because children receive their X chromosome from their mother, and daughters also receive an X chromosome from their father.
What does my AGTR2 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific AGTR2-related condition for families to rely on. If you have a specific AGTR2 result, what it means for relatives depends on the exact change found and the health picture in your family.
Genetic information
Genetic testing
How you find out about variants
AGTR2 genetic testing looks for variants in the AGTR2 gene using DNA from blood or saliva. It is often included in a broader gene panel or exome test, where a lab reads the gene’s sequence and compares it with a reference to identify variants and classify them as benign, uncertain, or clinically significant.
When should I consider getting a genetic test?
There isn’t yet a broadly established reason to test the AGTR2 gene on its own. Testing decisions are usually made with a doctor or genetic counselor based on personal symptoms and family history, often as part of a broader genetic test rather than a single-gene test.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, but how much they explain varies with the condition and the type of variant involved. Other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or how strongly the drug acts on its target, so the same treatment may work differently from one person to another. These differences are common and can influence both how well a medicine works and how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way a person responds to medication. It studies connections between genes and drugs to help explain why treatments can work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the AGTR2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general medication concerns are best discussed with your doctor. AGTR2 has been studied in research on blood pressure and response to some blood pressure medicines, but these findings are not used to guide routine care.
History
Researchers identified the AGTR2 gene in the early 1990s while mapping the body’s receptors for angiotensin II, a hormone already known to affect blood pressure and fluid balance. Its discovery helped distinguish a second major receptor from the better known AGTR1 pathway, which changed how scientists viewed this hormone system. The AGTR2 gene was soon mapped to the X chromosome, adding another important clue for genetic research. From these first observations, research expanded steadily. Studies in the years that followed showed that AGTR2 is especially active before birth, which drew interest in heart, blood vessel, and brain development. Although AGTR2 has not entered public culture in the way some genes have, it remains an established part of cardiovascular genetics research.